BAVIS_1170X120_10-19-20

Lou Schmukler

Bristol-Myers Squibb opens expanded biologics facility

Bristol-Myers Squibb opens expanded biologics facility

DEVENS, Mass. — Bristol-Myers Squibb has completed a major expansion of its biologics facility in Devens, Mass. The drug maker said the $280 million project will spur development of the company’s growing portfolio of biologics medicines. With the expansion, the 89-acre Devens campus received two new buildings: a biologics development building for designing processes for